 |
|
| Blog results | Results 1 - 10 of about 116,492 for prostate cancer drug. (0.19 seconds) |
| Sorted by relevance Sort by date |
| Related Blogs: | Prostate Cancer Blog for Wives and Partners - http://www.hisprostatecancer.com/Prostate-cancer-blog.html Advanced Prostate Cancer - http://advancedprostatecancer.net/ Help Prevent Cancer With Spray Vitamins! | Prostate - http://maleprostatenews.com/ HeartSpring.net - Alternative and Complementary Medicine ... - http://heartspring.net/ | |
| 11 hours ago A bitter ingredient found in hops has been shown to inhibit prostate cancer in animals. ... However, Durado Brooks of the American Cancer Society disagreed. He said that showing that something works in a test tube and impacts rat prostates was a long way from demonstrating any sort of viability in humans, and that he believed the drug finasteride (Proscar), which has been shown to reduce risk, was a better choice, although taking drugs can be a risky option. ... Healthcare Today - Health News - http://www.hc2d.co.uk/ |
| 14 Dec 2009 by The Childrens Hospital Of Philadelphia Britain's GlaxoSmithKline pulls application to sell enlarged prostate drug for blocking cancer. November 23rd, 2009 GlaxoSmithKline pulls application for new drug useTRENTON, N.J. — British drugmaker GlaxoSmithKline PLC said Monday it ... PR Hub - http://blog.taragana.com/pr/ - References [ More results from PR Hub ] |
| 10 Dec 2009 by Luke Timmerman It is composed of a genetically engineered protein found on prostate cancer cells, called PAP, fused to an immune-boosting compound, called GM-CSF. This fusion protein is incubated for a couple of days with an individual patient's own ... Xconomy - http://www.xconomy.com/ [ More results from Xconomy ] |
| 14 Dec 2009 by AP The company is also studying the vaccine to prevent relapse in prostate cancer patients. Shares of Generex Biotechnology Corp. rose 5 cents, or 7.8 percent, to 68 cents in afterhours trading. « Previous Topic ... October 5th, 2009 SciClone tumbles after cancer drug trial stopsNEW YORK — Shares of SciClone Pharmaceuticals Inc. dropped Monday after the company suspended a study of its drug candidate RP101, which was intended as a treatment for late stage pancreatic cancer. ... Health News - http://blog.taragana.com/health/ [ More results from Health News ] |
| 30 Nov 2009 Men with prostate cancer may be eligible to participate in a clinical study examining the safety and effectiveness of a new drug. DukeHealth.org: Duke Clinical Trials - http://www.dukehealth.org/?utm_source=dukehealth.org&utm_m... |
| 10 Dec 2009 by experienceseeker Dendreon Raises $356 Million for Manufacturing, Marketing for Prostate Cancer Drug http://bit.ly/50hqkA. experienceseeker timeline - http://identi.ca/experienceseeker |
| 8 Dec 2009 Hot flushes in men receiving hormone therapy for prostate cancer should be treated with medroxyprogesterone. Pharmacy Europe - http://www.pharmacyeurope.net/rss.asp - References |
| 13 hours ago by admin A 10 year study of more than 30000 men proved that people who take statin drugs to lower cholesterol have a lower prostate cancer risk. Breast cancer also found better numbers with statins. The FDA just approved Avastin for colon ... Individual HealthCare Coverage - http://www.health-care-programs.com/ |
| 28 Nov 2009 by GLG Expert Contributor Glaxo Smith Kline has withdrawn their supplemental New Drug Application for Avodart (dutasteride) in order to update their application. This drug has great promise for this disease. GLG News(sm): Healthcare - http://www.glgroup.com/Council-News-Listing/Healthcare-1.html |
| 18 hours ago by admin Cancer has been found to be “mediated” by virus cells for many cancers. However, there are several cancers – prostate, cervical, vagina and breast cancers that are mediated by hormones, and vitamin C is impotent against these. ... my disabled friend finder's blog - http://mydisabledfriendfinder.com/blogz/ |
Stay up to date on these results:
| Google Home - About Google Blog Search Beta - Information for Blog Authors |
